Hung Fai Poon | Chief Scientific Officer
Zhejiang Hisun Pharmaceuticals. Ltd | China

Hung Fai Poon, Chief Scientific Officer, Zhejiang Hisun Pharmaceuticals. Ltd

Dr. Poon is currently the CSO of Hisun Pharma – Biopharm. He previously worked for SAFC, Roskamp Institute in USA. He completed his Ph.D. in Biological Chemistry at University of Kentucky, and MBA from University of South Florida. He has years of experience in the field of biological, analytical research, bioinformatics and proteomics. He has more than 10 years of cell culture experience with focus on biopharmaceutical products.
 
He published more than 30 peer-reviewed articles, and contributes to more than 5 book chapters. He is currently the associate Editor for Journal of Chemistry, Biochemistry and Molecular Biology, and Journal of Bioinformatics and Biometrics.

Appearances:



Phar-East Day Two @ 11:10

Platform tech development for biosimilar upscaling

  • Discover strategies to move candidate molecules through development
  • Building consistent, straightforward processes with low variability
  • Exploring the possibility of using single use, high throughput bioreactors in the upscaling process

back to speakers